Answers are grounded in this paper and cite their sources.
Moderate-to-very severe COPD represents a considerable economic burden for healthcare providers despite the availability of efficacious treatments and comprehensive guidelines on their use. Further research is warranted to ensure cost-efficient COPD management, to improve treatments and ease budgetary pressures.
No takes yet. Share an insight, caveat, or question.
Iheanacho et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: